, high TILs infiltration was associated with improved disease-free and overall survival in triple-negative patients, but shorter overall survival in HR-positive, HER2-negative tumors [11], indicating a crucial need to better profile the TIME status in luminal breast cancer. Here, ERBB2 is linked to breast cancer.